Novosteo

Novosteo was established to reduce the incidence, mortality, and productivity loss associated with fractures. Based on breakthroughs in the discovery of drugs that accelerate bone regeneration and methods to selectively target these drugs to fracture surfaces, Novosteo has developed a series of fracture-targeted drugs that focus the healing power of medications specifically on the fracture site, significantly accelerating and improving the healing process at that location. Novosteo's mission is to mitigate the life-threatening impact of fractures on patients.